4.6 Review

Role of Cholinergic Signaling in Alzheimer's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects

Wei Yin et al.

Summary: The study on TAK-071 in humans showed favorable safety and tolerability profiles, with excellent brain penetration. Coadministration with donepezil did not impact the pharmacokinetics. Quantitative EEG analysis demonstrated significant effects on brain activity, but high doses of TAK-071 may reduce functional connectivity.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Review Neurosciences

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

Gabriella Marucci et al.

Summary: Alzheimer's disease is characterized by cognitive decline and behavioral manifestations, with the most common treatment being cholinesterase inhibitors. Despite their limited efficacy and gastrointestinal side effects, ChE-Is remain a pharmacotherapeutic resource for AD treatment. Investigating combinations with other drug classes may offer renewed interest in the use of ChE-Is for adult-onset dementia disorders.

NEUROPHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Human amyloid beta and a-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans

Xiaobing Huang et al.

Summary: The study found that the co-expression of A beta and alpha-synuclein in the brains of patients with Lewy body dementia may exacerbate the pathogenic process. The experimental results showed that co-expression of A beta and alpha-syn (A53T) in C. elegans further aggravated movement, egg laying, signaling deficits, and dopaminergic neuron damage. These findings suggest a potential mechanism by which A beta may enhance alpha-syn pathogenesis in Lewy body dementia.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Neurosciences

Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor

Viviana Soto-Mercado et al.

Summary: The study evaluated the effect of synthetic cannabinoids on a familial Alzheimer's disease model and found that CP in combination with inverse agonists can inhibit intracellular beta amyloid aggregation, increase mitochondrial membrane potential, and decrease oxidative stress. However, the ability of CP to reverse extracellular beta amyloid levels and calcium influx dysregulation in response to acetylcholine stimuli is limited.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Neurosciences

Implications of Oligomeric Amyloid-Beta (oAβ42) Signaling through α7β2-Nicotinic Acetylcholine Receptors (nAChRs) on Basal Forebrain Cholinergic Neuronal Intrinsic Excitability and Cognitive Decline

Andrew A. George et al.

Summary: This study reveals the molecular mechanism behind the subnucleus-specific alterations in BFCN excitability caused by the interaction between oAβ(42) and nAChR receptors, as well as confirms the important role of α7β2-nAChR in oAβ(42)-induced cognitive decline.

JOURNAL OF NEUROSCIENCE (2021)

Article Neurosciences

The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain

Caterina Montani et al.

Summary: The cholinergic drug xanomeline, acting at M1/M4 muscarinic receptors, induces widespread functional activity changes in the rodent brain, including decreased connectivity in the neocortex and striatum, and increased functional connectivity within the nucleus accumbens. Moreover, its effects on phencyclidine and ketamine suggest a modulatory role in specific functional networks within the brain.

NEUROPSYCHOPHARMACOLOGY (2021)

Article Neurosciences

Absence of metabotropic glutamate receptor homolog(s) accelerates acetylcholine neurotransmission in Caenorhabditis elegans

Girish Sadananda et al.

Summary: Excitatory neurotransmitters Glutamate (Glu) and Acetylcholine (ACh) and their signaling pathways are impaired in Alzheimer's disease. The study shows that mGluRs influence ACh neurotransmission and could serve as potential drug targets for AD.

NEUROSCIENCE LETTERS (2021)

Article Neurosciences

Nicotinic receptor modulation of the default mode network

Britta Hahn et al.

Summary: This study found that nAChR antagonist can weaken task-induced deactivation of the DMN, indicating that the constant activation tone of nAChR typically helps regulate DMN activity in healthy individuals. This implies that low nAChR tone may play a causal role in DMN dysregulation seen in conditions such as mild cognitive impairment or Alzheimer's disease.

PSYCHOPHARMACOLOGY (2021)

Article Behavioral Sciences

Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer's disease

Samah Labban et al.

Summary: This study showed that melatonin and resveratrol had positive effects on improving memory deficits in a sporadic mouse model of Alzheimer's disease, with better outcomes when used in combination. Additionally, both substances enhanced the cholinergic system and BDNF, CREB signaling pathways in the prefrontal cortex in the AD mouse model.

BEHAVIOURAL BRAIN RESEARCH (2021)

Review Biochemistry & Molecular Biology

The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease

Rola A. Bekdash

Summary: Neurodegenerative diseases, particularly Alzheimer's disease, are associated with dysregulation of cholinergic and adrenergic signaling systems, leading to the degeneration of specific neurons. Understanding and targeting these systems may have therapeutic implications for treating Alzheimer's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Aβ1-16 controls synaptic vesicle pools at excitatory synapses via cholinergic modulation of synapsin phosphorylation

Daniela Anni et al.

Summary: The study shows that Aβ 1-42 and Aβ 1-16 can increase the size of the recycling pool of synaptic vesicles, driven by enhanced endogenous cholinergic signaling.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Neurosciences

Altered basal forebrain BOLD signal variability at rest in posttraumatic stress disorder: A potential candidate vulnerability mechanism for neurodegeneration in PTSD

Isadora Olive et al.

Summary: This study found that individuals with the dissociative subtype of PTSD exhibited increased BOLD signal variability in two nuclei of the basal forebrain, potentially serving as a vulnerability mechanism for neurodegenerative diseases. The abnormalities observed may involve neurovascular uncoupling, decreased neural network connectivity, and disrupted dopamine circuits as etiological mechanisms.

HUMAN BRAIN MAPPING (2021)

Article Endocrinology & Metabolism

Ang (1-7)/Mas receptor-axis activation promotes amyloid beta-induced altered mitochondrial bioenergetics in discrete brain regions of Alzheimer's disease-like rats

Vibhav Varshney et al.

Summary: The Renin-Angiotensin System plays a significant role in the pathophysiology of Alzheimer's disease, with Ang (1?7) showing potential in ameliorating cognitive impairment. Injection of A842 induced changes in behavior, biochemistry, and molecular observations in rats.

NEUROPEPTIDES (2021)

Review Biochemistry & Molecular Biology

Neuroprotective Herbs for the Management of Alzheimer's Disease

Julie Gregory et al.

Summary: This study systematically reviews recent research on the role of neuroprotective herbs and their bioactive compounds in dementia associated with Alzheimer's disease. Medicinal plants have great potential in preventing and treating cognitive decline related to AD, and they can potentially be used in drug discovery programs to identify safe and effective small molecules for AD.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease

Alberto Llorente-Ovejero et al.

Summary: The study demonstrates that the loss of BFCN results in alterations of lipid species related to Ch metabolism at NMB and cortical projection areas, along with changes in mAChR activity in the brain. These findings suggest that targeting specific lipid metabolic pathways could be a potential therapeutic strategy for improving cholinergic neurotransmission and preserving cell membrane integrity in AD.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors

Sigrid Schwarthoff et al.

Summary: Newly evaluated compounds showed promising NMDA receptor blocking and moderate AChE inhibitory activities, with a higher selectivity towards BChE which may be beneficial for treating Alzheimer's disease. The compounds displayed balanced inhibitory activities against both NMDA receptors and AChE, potentially allowing for equal dosing against multiple targets in AD patients.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Palonosetron/Methyllycaconitine Deactivate Hippocampal Microglia 1, Inflammasome Assembly and Pyroptosis to Enhance Cognition in a Novel Model of Neuroinflammation

Reem A. Mohamed et al.

Summary: In this study, a novel model for sporadic AD was developed by injecting LPS into HFFD-fed rats, and the neuroprotective potential of palonosetron and/or methyllycaconitine was evaluated. The findings suggest that palonosetron alone or in combination with methyllycaconitine improved histopathological findings, enhanced spatial memory, and promoted animal performance during novel object recognition tests in HFFD/LPS rats. Additionally, the regimens reduced neuroinflammation and inflammasome cascade, restored microglial function, and upregulated ACh and 5-HT levels, indicating a potential therapeutic strategy for AD.

MOLECULES (2021)

Review Biochemistry & Molecular Biology

Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies

Dapinder Kaur et al.

Summary: Alzheimer's disease is a common neurodegenerative disorder in elderly people, with cognitive impairment, characterized by extracellular Ass plaques and intracellular NFTs. Current research on AD focuses on Ass aggregation, tau hyperphosphorylation, impaired cholinergic signaling, neuroinflammation, and autophagy, but no single theory can fully describe the pathophysiological changes in AD.

NEUROCHEMICAL RESEARCH (2021)

Review Pharmacology & Pharmacy

Functionally selective and biased agonists of muscarinic receptors

Alena Randakova et al.

Summary: Cholinergic signalling disruption through muscarinic receptors is linked to various pathologies, with potential therapeutic benefits found in selective muscarinic agonists. The identical orthosteric binding site across all muscarinic receptor subtypes makes the development of affinity-based selective agonists nearly impossible. Functionally selective and biased agonists show promise for selectively targeting individual muscarinic receptor subtypes.

PHARMACOLOGICAL RESEARCH (2021)

Article Multidisciplinary Sciences

Locomotion dependent neuron-glia interactions control neurogenesis and regeneration in the adult zebrafish spinal cord

Weipang Chang et al.

Summary: The study shows that physical exercise can activate neurogenesis in the spinal cord of adult zebrafish through cholinergic neurotransmission and a reduction of GABA(A) receptors. The researchers also found that functional recovery after spinal cord injury can be promoted by stimulating cholinergic receptors and interfering with GABAergic signaling. The findings suggest a model for activity-dependent neurogenesis in the adult zebrafish spinal cord during homeostasis and regeneration.

NATURE COMMUNICATIONS (2021)

Review Geriatrics & Gerontology

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain

Anna Gasiorowska et al.

Summary: The global elderly population is growing, leading to various changes in the brain related to cognitive decline and neurobehavioral deficits. Aging is a significant risk factor for functional worsening, disease exaggeration, and dementia, with life stress and trauma potentially accelerating age-related disorders. Understanding the mechanisms of age-related diseases can aid in the development of effective treatment strategies.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Chemistry, Medicinal

Tadalafil Reversed H-89 - and Scopolamine - Induced Spatial Learning Impairments in Male Rats

Kaveh Tabrizian et al.

Summary: The cAMP and cGMP signaling pathways play important roles in memory function and neuronal plasticity. In this study, the combination of tadalafil with other drugs showed potential in reversing spatial learning deficits in an Alzheimer's disease model.

DRUG RESEARCH (2021)

Article Biochemistry & Molecular Biology

β-Amyrin Ameliorates Alzheimer's Disease-Like Aberrant Synaptic Plasticity in the Mouse Hippocampus

Hye Jin Park et al.

BIOMOLECULES & THERAPEUTICS (2020)

Article Chemistry, Medicinal

Natural products and their derivatives as multifunctional ligands against Alzheimer's disease

Pooja Patil et al.

DRUG DEVELOPMENT RESEARCH (2020)

Review Clinical Neurology

Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer's Disease

Aston J. Wu et al.

CURRENT ALZHEIMER RESEARCH (2020)

Article Biochemistry & Molecular Biology

Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs

Sophie J. Bradley et al.

NATURE CHEMICAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Circular RNA expression profile of Alzheimer's disease and its clinical significance as biomarkers for the disease risk and progression

Yuanlong Li et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Amyloid beta (1-42) downregulates adenosine-2b receptors in addition to mitochondrial impairment and cholinergic dysfunction in memory-sensitive mouse brain regions

Bhupesh Chandra Semwal et al.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2020)

Review Neurosciences

Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation

Rashmi Gamage et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Article Food Science & Technology

Phycocyanin alleviates ICV-STZ induced cognitive and molecular deficits via PI3-Kinase dependent pathway

Madhunika Agrawal et al.

FOOD AND CHEMICAL TOXICOLOGY (2020)

Review Endocrinology & Metabolism

Adiponectin and sporadic Alzheimer's disease: Clinical and molecular links

Liliana Letra et al.

FRONTIERS IN NEUROENDOCRINOLOGY (2019)

Review Neurosciences

ProNGF and Neurodegeneration in Alzheimer's Disease

Margaret Fahnestock et al.

FRONTIERS IN NEUROSCIENCE (2019)

Review Neurosciences

Innovative Therapy for Alzheimer's Disease-With Focus on Biodelivery of NGF

Sumonto Mitra et al.

FRONTIERS IN NEUROSCIENCE (2019)

Review Ophthalmology

Cholinergic nervous system and glaucoma: From basic science to clinical applications

Muneeb A. Faiq et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2019)

Article Behavioral Sciences

Corticolimbic analysis of microRNAs and protein expressions in scopolamine-induced memory loss under stress

Mehdi Eivani et al.

NEUROBIOLOGY OF LEARNING AND MEMORY (2019)

Review Biochemistry & Molecular Biology

Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer's Disease

Huan Wang et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

Classics in Chemical Neuroscience: Donepezil

James T. Brewster et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Review Geriatrics & Gerontology

Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease

Puneet Talwar et al.

FRONTIERS IN AGING NEUROSCIENCE (2019)

Article Neurosciences

Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease

Benedicte Foveau et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Review Pharmacology & Pharmacy

Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels

Kohji Fukunaga et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)

Article Biochemistry & Molecular Biology

Role for calcium signaling in manganese neurotoxicity

Omamuyovwi M. Ijomone et al.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2019)

Review Pharmacology & Pharmacy

Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders

Sean P. Moran et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Review Biochemistry & Molecular Biology

Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets

Mariela L. Paz et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

History and progress of hypotheses and clinical trials for Alzheimer's disease

Pei-Pei Liu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)

Review Medicine, Research & Experimental

A molecular approach in drug development for Alzheimer's disease

Snezana Agatonovic-Kustrin et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Neurosciences

Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease

Alberto Llorente-Ovejero et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Review Biochemistry & Molecular Biology

The GABAergic system as a therapeutic target for Alzheimer's disease

Beatriz Calvo-Flores Guzman et al.

JOURNAL OF NEUROCHEMISTRY (2018)

Article Neurosciences

Multimodal Encoding of Novelty, Reward, and Learning in the Primate Nucleus Basalis of Meynert

Clarissa Martinez-Rubio et al.

JOURNAL OF NEUROSCIENCE (2018)

Article Neurosciences

Estrogen Protects Neurotransmission Transcriptome During Status Epilepticus

Dumitru A. Iacobas et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Pharmacology & Pharmacy

Moringa oleifera Seed Extract Alleviates Scopolamine-Induced Learning and Memory Impairment in Mice

Juan Zhou et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Behavioral Sciences

Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease

Abhishek B. Jha et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)

Article Computer Science, Interdisciplinary Applications

Gene expression profiling of midbrain dopamine neurons upon gestational nicotine exposure

Pinar Kanlikilicer et al.

MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING (2017)

Article Biochemistry & Molecular Biology

Early and Late Pathomechanisms in Alzheimer's Disease: From Zinc to Amyloid-β Neurotoxicity

Andrzej Szutowicz et al.

NEUROCHEMICAL RESEARCH (2017)

Article Neurosciences

Neuron-Astrocyte Signaling is Preserved in the Aging Brain

Marta Gomez-Gonzalo et al.

Review Biochemistry & Molecular Biology

The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology

Nadia Canu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Neurosciences

The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment

Inelia Morales et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Review Biochemistry & Molecular Biology

Personalized genetics of the cholinergic blockade of neuroinflammation

Alon Simchovitz et al.

JOURNAL OF NEUROCHEMISTRY (2017)

Article Neurosciences

Chronic nicotine treatment decreases LPS signaling through NF-κB and TLR-4 modulation in the hippocampus

Cecilia Cerqueira Cafe-Mendes et al.

NEUROSCIENCE LETTERS (2017)

Article Biochemistry & Molecular Biology

Lipid mapping of the rat brain for models of disease

J. Martinez-Gardeazabal et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)

Review Cell Biology

Drug candidates in clinical trials for Alzheimer's disease

Shih-Ya Hung et al.

JOURNAL OF BIOMEDICAL SCIENCE (2017)

Article Biochemistry & Molecular Biology

AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's disease

Natalia N. Nalivaeva et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2016)

Review Clinical Neurology

Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research

U. Damar et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)

Article Medicine, Research & Experimental

Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration

Wei Xu et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Biochemistry & Molecular Biology

Pharmacological evidence of specific acetylcholine transport in rat cerebral cortex and other brain regions

Ikunobu Muramatsu et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Biochemical Research Methods

Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells

Hu Yao et al.

JOURNAL OF NEUROSCIENCE METHODS (2016)

Article Biochemistry & Molecular Biology

Lactucopicrin ameliorates oxidative stress mediated by scopolamine-induced neurotoxicity through activation of the NRF2 pathway

Ramu Venkatesan et al.

NEUROCHEMISTRY INTERNATIONAL (2016)

Review Neurosciences

Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease

Lana M. Osborn et al.

PROGRESS IN NEUROBIOLOGY (2016)

Review Clinical Neurology

Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research

U. Damar et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)

Review Biochemistry & Molecular Biology

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease

Andrea Kwakowsky et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Neurosciences

Acetylcholinesterase Modulates Presenilin-1 Levels and γ-Secretase Activity

Maria-Letizia Campanari et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

Article Clinical Neurology

Rapid β-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice

Juan Jose Ramos-Rodriguez et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)